Intended for healthcare professionals

CCBYNC Open access
Research

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n84 (Published 20 January 2021) Cite this as: BMJ 2021;372:n84

Linked Editorial

Covid-19 controversies: the tocilizumab chapter

Linked News

Arthritis drug trial for severe illness is stopped early after increase in deaths